This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slid 7.54% to $21.47 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.54% to 11,183.66 and Dow Jones Industrial Average falling 0.12% to 33,553.83. Novavax Inc. closed $215.03 short of its 52-week high ($236.50), which the company achieved on December 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Replimune Group Inc. (REPL) fell 2.39% to $19.22, VBI Vaccines Inc. (VBIV) fell 6.91% to $0.64, and AnaptysBio Inc. (ANAB) fell 5.31% to $28.37. Trading volume (3.8 M) remained 1.4 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 16, 2022.
(END) Dow Jones Newswires
November 16, 2022 17:13 ET (22:13 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.